These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 32381288)
1. Covid-19: The challenges facing endocrinology. Pugeat M; Chabre O; Van Tyghem MC Ann Endocrinol (Paris); 2020 Jun; 81(2-3):61-62. PubMed ID: 32381288 [No Abstract] [Full Text] [Related]
2. Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis. Xu J; Huang C; Fan G; Liu Z; Shang L; Zhou F; Wang Y; Yu J; Yang L; Xie K; Huang Z; Huang L; Gu X; Li H; Zhang Y; Wang Y; Hayden FG; Horby PW; Cao B; Wang C Front Med; 2020 Oct; 14(5):601-612. PubMed ID: 32621202 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers are not associated with increased risk of SARS-CoV-2 infection. Chodick G; Nutman A; Yiekutiel N; Shalev V J Travel Med; 2020 Aug; 27(5):. PubMed ID: 32406512 [TBL] [Abstract][Full Text] [Related]
4. Telemedicine During the COVID-19 Crisis and Beyond. Blevins T; Ozer K Tex Med; 2020 Jul; 116(7):4-5. PubMed ID: 32872703 [TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin system inhibitors and the severity of coronavirus disease 2019 in Kanagawa, Japan: a retrospective cohort study. Matsuzawa Y; Ogawa H; Kimura K; Konishi M; Kirigaya J; Fukui K; Tsukahara K; Shimizu H; Iwabuchi K; Yamada Y; Saka K; Takeuchi I; Hirano T; Tamura K Hypertens Res; 2020 Nov; 43(11):1257-1266. PubMed ID: 32820236 [TBL] [Abstract][Full Text] [Related]
6. COVID-19, chronic inflammatory respiratory diseases and eosinophils-Observations from reported clinical case series. Jesenak M; Banovcin P; Diamant Z Allergy; 2020 Jul; 75(7):1819-1822. PubMed ID: 32369190 [No Abstract] [Full Text] [Related]
7. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Singh AK; Gupta R; Ghosh A; Misra A Diabetes Metab Syndr; 2020; 14(4):303-310. PubMed ID: 32298981 [TBL] [Abstract][Full Text] [Related]
8. [Smoking and coronavirus disease 2019 (COVID-19)]. Underner M; Peiffer G; Perriot J; Jaafari N Rev Mal Respir; 2020 May; 37(5):433-436. PubMed ID: 32331829 [No Abstract] [Full Text] [Related]
9. How do we recover from COVID-19? Helping diabetes teams foresee and prepare for the psychological harms. Stewart R Diabet Med; 2020 Oct; 37(10):1655-1657. PubMed ID: 32632989 [No Abstract] [Full Text] [Related]
10. [Diabetes and hypertension as factors associated with Covid-19 lethality in Sonora, Mexico, 2020]. Álvarez-López DI; Espinoza-Molina MP; Cruz-Loustaunau ID; Álvarez-Hernández G Salud Publica Mex; 2020; 62(5):456-457. PubMed ID: 33027852 [No Abstract] [Full Text] [Related]
11. ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovation. Wake DJ; Gibb FW; Kar P; Kennon B; Klonoff DC; Rayman G; Rutter MK; Sainsbury C; Semple RK Eur J Endocrinol; 2020 Aug; 183(2):G67-G77. PubMed ID: 32508313 [TBL] [Abstract][Full Text] [Related]
12. Male predisposition to severe COVID-19: Review of evidence and potential therapeutic prospects. Acheampong DO; Barffour IK; Boye A; Aninagyei E; Ocansey S; Morna MT Biomed Pharmacother; 2020 Nov; 131():110748. PubMed ID: 33152916 [TBL] [Abstract][Full Text] [Related]
13. ACE inhibitors and COVID-19: We don't know yet. Khashkhusha TR; Chan JSK; Harky A J Card Surg; 2020 Jun; 35(6):1172-1173. PubMed ID: 32340070 [No Abstract] [Full Text] [Related]
14. Viral Evolution will Automatically Resolve COVID-19 Pandemic. Sharma D Comb Chem High Throughput Screen; 2020; 23(8):686. PubMed ID: 32713339 [No Abstract] [Full Text] [Related]
15. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study. Yang G; Tan Z; Zhou L; Yang M; Peng L; Liu J; Cai J; Yang R; Han J; Huang Y; He S Hypertension; 2020 Jul; 76(1):51-58. PubMed ID: 32348166 [TBL] [Abstract][Full Text] [Related]
16. The effects of renin-angiotensin system inhibitors (RASI) in coronavirus disease (COVID-19) with hypertension: A retrospective, single-center trial. Cui H; Wu F; Fan Z; Cheng X; Cheng J; Fan M Med Clin (Barc); 2020 Oct; 155(7):295-298. PubMed ID: 32747012 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin converting enzyme inhibitors do not increase the risk of poor outcomes in COVID-19 disease. A multi-centre observational study. Khan KS; Reed-Embleton H; Lewis J; Bain P; Mahmud S Scott Med J; 2020 Nov; 65(4):149-153. PubMed ID: 32873147 [TBL] [Abstract][Full Text] [Related]
18. The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the "Ariadne's thread" for the "labyrinth" of COVID-19. Tsioufis C; Dimitriadis K; Tousoulis D Hellenic J Cardiol; 2020; 61(1):31-33. PubMed ID: 32450334 [No Abstract] [Full Text] [Related]
19. Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence. Turgeon RD; Zieroth S; Bewick D; Chow CM; Clarke B; Cowan S; Fordyce CB; Fournier A; Gin K; Gupta A; Hardiman S; Jackson S; Lau B; Leong-Poi H; Mansour S; Marelli A; Quraishi AR; Roifman I; Ruel M; Sapp J; Singh G; Small G; Virani S; Wood DA; Krahn A Can J Cardiol; 2020 Aug; 36(8):1180-1182. PubMed ID: 32502522 [No Abstract] [Full Text] [Related]
20. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis. Guo X; Zhu Y; Hong Y Hypertension; 2020 Aug; 76(2):e13-e14. PubMed ID: 32458694 [No Abstract] [Full Text] [Related] [Next] [New Search]